Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 32,904 | 29,199 | 31,109 | 34,529 | 33,065 |
| Operating Income | -32,904 | -29,199 | -31,109 | -34,529 | -33,065 |
| Other Income | 2,406 | 2,052 | 1,311 | 1,661 | 1,576 |
| Pre-tax Income | -30,498 | -27,147 | -29,798 | -32,868 | -31,489 |
| Income Tax | N/A | N/A | -1,133 | 17 | 21 |
| Net Income Continuous | -30,498 | -27,147 | -28,665 | -32,885 | -31,510 |
| Net Income | $-30,498 | $-27,147 | $-28,665 | $-32,885 | $-31,510 |
| EPS Basic Total Ops | -1.46 | -1.65 | -2.82 | -3.26 | -3.13 |
| EPS Basic Continuous Ops | -1.46 | -1.65 | -2.83 | -3.26 | -3.13 |
| EPS Diluted Total Ops | -1.46 | -1.65 | -2.82 | -3.26 | -3.13 |
| EPS Diluted Continuous Ops | -1.46 | -1.65 | -2.83 | -3.26 | -3.13 |
| EPS Diluted Before Non-Recurring Items | -0.89 | -1.50 | -2.30 | N/A | N/A |
| EBITDA(a) | $-32,390 | $-28,535 | $-30,200 | $-33,180 | $-32,246 |